In turn, IAP treatment significantly decreased SOD activity as compared to the value observed in non-obese treadmill-running mice with colitis, and this value reached a significantly lower level than that recorded in control mice without IAP administration (p < 0.05, Figure 3). The gene discussed is SOD1; the disease is colitis.